|
|
| Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles |
| Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles |
|
|